267 related articles for article (PubMed ID: 30617391)
1. In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures.
Wagmann L; Richter LHJ; Kehl T; Wack F; Bergstrand MP; Brandt SD; Stratford A; Maurer HH; Meyer MR
Anal Bioanal Chem; 2019 Jul; 411(19):4751-4763. PubMed ID: 30617391
[TBL] [Abstract][Full Text] [Related]
2. Return of the lysergamides. Part III: Analytical characterization of N
Brandt SD; Kavanagh PV; Westphal F; Elliott SP; Wallach J; Stratford A; Nichols DE; Halberstadt AL
Drug Test Anal; 2017 Oct; 9(10):1641-1649. PubMed ID: 28342178
[TBL] [Abstract][Full Text] [Related]
3. Return of the lysergamides. Part II: Analytical and behavioural characterization of N
Brandt SD; Kavanagh PV; Westphal F; Elliott SP; Wallach J; Colestock T; Burrow TE; Chapman SJ; Stratford A; Nichols DE; Halberstadt AL
Drug Test Anal; 2017 Jan; 9(1):38-50. PubMed ID: 27265891
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
[TBL] [Abstract][Full Text] [Related]
5. Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Halberstadt AL
Drug Test Anal; 2020 Oct; 12(10):1514-1521. PubMed ID: 32803833
[TBL] [Abstract][Full Text] [Related]
6. Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions.
Grumann C; Henkel K; Stratford A; Hermanns-Clausen M; Passie T; Brandt SD; Auwärter V
J Pharm Biomed Anal; 2019 Sep; 174():270-276. PubMed ID: 31181490
[TBL] [Abstract][Full Text] [Related]
7. [Identification and Analysis of LSD Derivatives in Illegal Products as Paper Sheet].
Tanaka R; Kawamura M; Hakamatsuka T; Kikura-Hanajiri R
Yakugaku Zasshi; 2020; 140(5):739-750. PubMed ID: 32378678
[TBL] [Abstract][Full Text] [Related]
8. Identification of LSD analogs, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD and LSZ in sheet products.
Tanaka R; Kawamura M; Mizutani S; Kikura-Hanajiri R
Forensic Toxicol; 2023 Jul; 41(2):294-303. PubMed ID: 36809464
[TBL] [Abstract][Full Text] [Related]
9. Identification of 1-Butyl-Lysergic Acid Diethylamide (1B-LSD) in Seized Blotter Paper Using an Integrated Workflow of Analytical Techniques and Chemo-Informatics.
Tsochatzis E; Lopes JA; Reniero F; Holland M; Åberg J; Guillou C
Molecules; 2020 Feb; 25(3):. PubMed ID: 32045999
[TBL] [Abstract][Full Text] [Related]
10. Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.
Brandt SD; Kavanagh PV; Westphal F; Pulver B; Schwelm HM; Whitelock K; Stratford A; Auwärter V; Halberstadt AL
Drug Test Anal; 2022 Aug; 14(8):1503-1518. PubMed ID: 35524430
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
Michely JA; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
[TBL] [Abstract][Full Text] [Related]
12. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
[TBL] [Abstract][Full Text] [Related]
13. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
Caspar AT; Westphal F; Meyer MR; Maurer HH
Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
[TBL] [Abstract][Full Text] [Related]
14. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
[TBL] [Abstract][Full Text] [Related]
15. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and analytical characterization of 1-(2-thienoyl)-6-allyl-nor-d-lysergic acid diethylamide (1T-AL-LAD).
Okada Y; Segawa H; Yamamuro T; Kuwayama K; Tsujikawa K; Kanamori T; Iwata YT
Drug Test Anal; 2024 Jun; ():. PubMed ID: 38922764
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
[TBL] [Abstract][Full Text] [Related]
18. Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).
Brandt SD; Kavanagh PV; Twamley B; Westphal F; Elliott SP; Wallach J; Stratford A; Klein LM; McCorvy JD; Nichols DE; Halberstadt AL
Drug Test Anal; 2018 Feb; 10(2):310-322. PubMed ID: 28585392
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of LSD in vitro metabolism by liquid chromatography and capillary electrophoresis coupled with tandem mass spectrometry.
Cai J; Henion J
J Anal Toxicol; 1996; 20(1):27-37. PubMed ID: 8837948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
